Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Urban Scheuring, M.D., Ph.D.
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
117 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Barretos, Brazil
- Research Site
Fortaleza, Brazil
- Research Site
Londrina, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Rio de Janeiro, Brazil
- Research Site
São José do Rio Preto, Brazil
- Research Site
São Paulo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Antofagasta, Chile
- Research Site
Santiago, Chile
- Research Site
Santiago, Chile
- Research Site
Santiago, Chile
- Research Site
Temuco, Chile
- Research Site
Temuco, Chile
- Research Site
Viña del Mar, Chile
- Research Site
Changchun, China
- Research Site
Changsha, China
- Research Site
Chengdu, China
- Research Site
Chongqing, China
- Research Site
Guangzhou, China
- Research Site
Hangzhou, China
- Research Site
Hefei, China
- Research Site
Hefei, China
- Research Site
Shanghai, China
- Research Site
Shenyang, China
- Research Site
Shenyang, China
- Research Site
Tianjin, China
- Research Site
Wuhan, China
- Research Site
Wuhan, China
- Research Site
Budapest, Hungary
- Research Site
Debrecen, Hungary
- Research Site
Győr, Hungary
- Research Site
Kaposvár, Hungary
- Research Site
Szeged, Hungary
- Research Site
Ahmedabad, India
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Feb 2019
- Primary completion
- 20 Jan 2022
- Completion
- 3 Jul 2023
- Last update posted
- 26 Jul 2024
- Registered enrollment
- 770
- Registry id
- NCT03830866
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.